Onconova, Conatus Price IPOs: $78M, $66M, Both with Upside
Onconova Therapeutics Inc. priced its shares higher than expected in an initial public offering (IPO), and Conatus Pharmaceuticals Inc., also pricing, rolled out 1 million more shares than originally targeted, to settle in the midrange of the targeted cost per share.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter